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microcirculation; functional capillary density; oxygen release; polyethylene glycol maleimide-conjugated hemoglobin; critical oxygen supply; NADH fluorescence HEMOGLOBIN (Hb)-based O 2 carriers (HbOCs) are being developed, in part, to supplement or substitute autologous blood transfusion use during surgical interventions, to provide additional O 2 -carrying capacity (23, 29) . The most extensively studied and financed blood substitute was diaspirin crosslinked Hb (40) . Intramolecular cross-linking of Hb overcame the nephrotoxicity but remained vasoconstrictive (40) . The vasoactivity was credited to nitric oxide (NO) scavenging, Hb extravasation, and vascular hyperoxygenation (40) . Polyethylene glycol (PEG)-conjugated bovine Hb was introduced by Enzon (17) . This product carried 10 copies of 5-kDa PEG chains conjugated to the protein using succinimidyl carbonate chemistry and was not vasoconstrictive (17) . Neutralization of vasoactivity was attributed to its enhanced molecular volume, viscosity, and high colloid osmotic pressure (COP), leading to a new approach for producing nonhypertensive Hb materials (33) .
The application of PEGylated Hb (PEG-Hb) as O 2 -carrying plasma expanders is counterintuitive to the conventional wisdom of O 2 -carrying blood substitutes, because PEG-Hb exhibits high O 2 affinity and is effective at low Hb concentrations. During experimental studies and clinical trials, PEG-Hb has been shown to be more effective than earlier formulations of blood substitute based on mimicking blood O 2 transport properties (high Hb concentration and normal O 2 affinity) (12, 38) . PEG-Hb is not a blood substitute in the conventional sense, since it is designed to deliver O 2 at a lower PO 2 than red blood cells (RBCs) (38) .
Experimental procedures that test the capacity of PEG-Hb to deliver O 2 to the tissue are limited by its high O 2 affinity, which precludes PEG-Hb taking part in the normal tissue O 2 supply when tissue PO 2 is ϳ20 Torr. Reducing O 2 availability lowers tissue PO 2 and allows PEG-Hb to release O 2 . However, O 2 release to the cellular O 2 metabolism cannot be confirmed by tissue PO 2 measurements, as they do not represent the oxidative state of the mitochondria. Since tissue PO 2 after extreme hemodilution with PEG-Hb does not increase compared with identical interventions using non-O 2 -carrying plasma expanders, techniques to study intracellular O 2 levels are needed to determine whether the circulation benefits from the presence of PEG-Hb (9) .
The NADH/NAD ϩ redox state is an indicator of the decrease of intracellular O 2 concentration (10, 11) , which causes NAD ϩ and other members of the mitochondrial respiratory chain to be reduced (10, 11) . Glycolysis yields pyruvate and ATP, in addition to NADH. When O 2 is present, the NADH generated by glycolysis is oxidized by the mitochondria via the electron transport chain, resulting in ATP and NAD ϩ . In the absence of enough intracellular O 2 or other causes of inhibition of the electron transport chain, NADH accumulates, and the supply of NAD ϩ is depleted. NADH concentration can be measured based on the difference in the absorption spectrum of its reduced form; however, this approach is not suitable to the study of mitochondria NADH levels. More specific than absorption spectroscopy, fluorescence spectrophotometry in the near-ultraviolet range can be applied for NADH measurements in vivo. NADH absorbs light at 320 -380 nm and emits fluorescent light at 420 -480 nm; therefore, it is possible to evaluate the redox state of the mitochondria by monitoring the fluorescence of NADH (31) .
We developed an experimental model in which NADH fluorescence can be recorded from the tissue of the hamster window model under different oxygenation conditions to as-sess changes in the NADH/NAD ϩ redox state of intact tissue to understand intracellular PO 2 changes (31). It should be noted that the hamster skinfold chamber model includes muscle and connective tissue. This model, in combination with systemic and microvascular parameters and microvascular O 2 levels after extreme hemodilution with PEG-Hb, was used to study how PEG-Hb induced changes in mitochondrial redox state. To achieve conditions of O 2 supply limitation, the experimental hamster window chamber model was subjected to moderate hemodilution (MH) via two isovolemic exchanges with 6% 70-kDa dextran (Dex70) to induce an acute anemic state (18% Hct). After this moderate anemia, the animals were randomly exchange-transfused with PEG-Hb [P5K6-Hb, 6 copies of 5-kDa PEG conjugated through extension arm chemistry (EAC) to each human Hb] or 6% Dex70 to a condition of extreme hemodilution (11% Hct). Changes in microvascular function were characterized by determining effects on capillary flow, microhemodynamic changes, and oxygenation, and the tissue O 2 state was assessed by NADH fluorescence.
METHODS
Animal preparation. Male golden Syrian hamsters (55-65 g body wt; Charles River Laboratories, Boston, MA) were fitted with a dorsal window chamber. Animal handling and care followed the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The experimental protocol was approved by the local animal care committee. The hamster window chamber model is widely used for microvascular studies in the unanesthetized state, and the complete surgical technique is described in detail elsewhere (13, 14) . Catheters were tunneled under the skin, exteriorized at the dorsal side of the neck, and securely attached to the window frame.
Inclusion criteria. Animals were suitable for the experiments if 1) systemic parameters were within normal range, namely, heart rate (HR) Ͼ340 beats/min, mean arterial blood pressure (MAP) Ͼ80 mmHg, systemic Hct Ͼ45%, and arterial PO 2 Ͼ50 Torr, and 2) microscopic examination of the tissue in the chamber observed under a ϫ650 magnification did not reveal signs of edema or bleeding.
Test materials. PEG-Hb (P5K6-Hb), succinimidophenyl PEG-Hb conjugate, was obtained through EAC of thiolated human Hb, with six copies of 5-kDa PEG, two of which are conjugated to the thiol of ␤-Cys 93 and four to the ε-amino groups of lysine residues. The latter is accomplished through EAC introduced by reaction of iminothiolane with Hb (to introduce sulfhydryl groups to lysine residues) (1, 3, 5, 26) . Hb (0.5 mM) was incubated with 5 mM iminothiolane in the presence of 10 mM 5-kDa maleimidophenyl PEG in PBS at 4°C overnight; then the PEGylated protein was isolated by tangential flow filtration (Minim, Pall, Port Washington, NY) with a 50-kDa membrane. The molecular mass of PEG-Hb is ϳ95,000. Concentrations of Hb refer to grams of Hb tetramer. O 2 equilibrium curves were measured using the method described previously (4) , and other physical characterizations were P 50 (i.e., PO2 at which Hb is 50% saturated with O2) of 5.6 Torr and Hill coefficient of 1.26.
O2 saturation. O2 saturation curves for hamster blood and PEG-Hb were obtained by deoxygenation of O2-equilibrated samples in Hemox buffer at 37°C using a Hemox analyzer (TCS Scientific, New Hope, PA).
Experimental groups. Animals were randomly divided into two experimental groups before the experiment: 1) Dex70 animals were treated with 6% 70-kDa dextran (Pharmacia, Uppsala, Sweden) and 2) PEG-Hb animals were treated with 4.0 g Hb/dl and 1.88 g PEG/dl.
Acute isovolemic exchange-transfusion (hemodilution) protocol. Acute anemia was induced by two isovolemic hemodilution steps, as described in detail in our previous reports (4, 6, 36) . Briefly, the volume of each exchange-transfusion step was calculated as a percentage of the blood volume, estimated as 7% of body weight. The acute anemic state was induced by lowering systemic Hct to 18% by progressive isovolemic hemodilution using 6 g Dex70/dl.
MH was randomly assigned to three experimental groups using a sorting scheme based on a list of random numbers (2) . Group 1 was used to study microvascular O 2 distribution at MH. In groups 2 and 3, 35% of blood volume was exchanged with Dex70 and PEG-Hb, respectively.
Blood was simultaneously withdrawn at the same rate from the carotid artery catheter according to a previously established protocol (4) . Blood samples were withdrawn at the end of the experiment for subsequent analysis of viscosity and COP. The duration of the experiments was 4 h. Each exchange and the respective observation time point after exchange were completed in 1 h. Systemic and microcirculation data were taken after a stabilization period of 10 min.
Systemic parameters. MAP and HR were recorded continuously (MP 150, Biopac System, Santa Barbara, CA). Hct was measured from centrifuged arterial blood samples collected in heparinized capillary tubes. Hb content was determined spectrophotometrically (B-Hemoglobin, Hemocue, Stockholm, Sweden).
Blood chemistry and biophysical properties. Arterial blood was collected in heparinized glass capillaries (50 l) and immediately analyzed for PO 2, PCO2, base excess, and pH with use of a blood chemistry analyzer (model 248, Bayer, Norwood, MA). Blood samples for viscosity and COP measurements were quickly withdrawn into heparinized 5-ml syringes at the end of the experiment. Viscosity was measured in a DV-II Plus (Brookfield, Middleboro, MA). COP was measured using a colloid osmometer (model 4420, Wescor, Logan, UT).
Microvascular experimental setup. The unanesthetized animal was placed in a restraining tube with a longitudinal slit from which the window chamber protruded and then fixed to the microscopic stage for transillumination with the intravital microscope (model BX51WI, Olympus, New Hyde Park, NY). Animals were given 20 min to adjust to the tube environment before any measurement. Tissue image was projected onto a charge-coupled device camera (COHU 4815) connected to a videocassette recorder and viewed on a monitor. Measurements were carried out using a ϫ40 (LUMPFL-WIR, 0.8 numerical aperture, Olympus) water-immersion objective. The same sites of study were followed throughout the experiment, so that comparisons could be made directly with baseline levels.
Functional capillary density. Functional capillaries, defined as those capillary segments that have RBC transit of at least a single RBC in a 45-s period in 10 successive microscopic fields, were assessed, totaling a region of 0.46 mm 2 . Each field had between two and five capillary segments with RBC flow. Functional capillary (FCD, cm Ϫ1 ), i.e., total length of RBC-perfused capillaries divided by area of microscopic field of view, was evaluated by measuring and adding the length of capillaries that had RBC transit in the field of view. The relative change in FCD from baseline levels after each intervention is indicative of the extent of capillary perfusion (7).
Microhemodynamics. A video image-shearing method was used to measure vessel diameter (D) (20) . Changes in arteriolar and venular diameter from baseline were used as indicators of a change in vascular tone. Arteriolar and venular centerline velocities were measured online by the photodiode cross-correlation method (photodiode/velocity tracker model 102B, Vista Electronics, San Diego, CA). The measured centerline velocity (V) was corrected according to vessel size to obtain the mean RBC velocity (24) . Blood flow (Q ) was calculated from the measured values as follows:
2 . This calculation assumes a parabolic velocity profile and has been found to be applicable to 15-to 80-m-ID tubes and 6 -60% Hct (24) .
Measurement of NADH.
Tissue fluorescence is a widely used and accepted method to measure NADH in vivo (15, 30 -32) . Areas of interest were located using the microscope, and the edge of the vessels was used to focus the image with bright-field transillumination and fluorescence epi-illumination. Fluorescence emission signals (420 and 460 nm filter; Thorslabs, Newton, NJ) were recorded using a photomultiplier (model R928, Hamamatsu) during fluorescent excitation (360 nm filter; Thorslabs) using a dichroic mirror (model XF2003 390DRLP, Omega Optical, Brattleboro, VT). The photomultiplier photometric head was mounted on the camera port of the trinocular head of the microscope. Fluorescence intensities were recorded as the tissue was excited (model MP 150, Biopac System; 200-Hz sampling rate). Filter wheels were rotated to switch from 420 to 460 nm. Fluorescence was excited with a mercury arc lamp (200 W); the lamp shutter was opened only for 2-s intervals to prevent photobleaching. To circumvent optical problems associated with thickness of the tissue, a partial confocal effect was created by placing a 150-m pinhole in the excitation light path (19) . The fluorescence ratio gives concentration-independent, NADH-sensitive fluorescence measurements (15, 30, 32) . Fluorescence ratio was formed as follows: R NADH ϭ (I460 Ϫ Iback460)/(I420 Ϫ Iback420). Background fluorescence intensities for each wavelength (Iback420 and Iback460) were recorded before fluorescent excitation.
Photometric assembly was combined with an adjustable rectangular diaphragm, mounted in front of the photomultiplier unit. The rectangular area was backilluminated and visualized through the binocular observation port with exact size and superimposed on the view field. This design allows precise location of the photometric window relative to the anatomic details of the study tissue. Photomultiplier signal output was calibrated in terms of the number of detected photons per unit area of emission. The photomultiplier current output was measured as voltage across a 10-k⍀ resistor. NADH fluorescence was detected at 0.5-1.0 V with a window size of 15 ϫ 15 m.
Microvascular PO 2 distribution. High-resolution noninvasive microvascular PO2 measurements were made using phosphorescence quenching microscopy (PQM) (21, 36) . PQM is based on the O2-dependent quenching of phosphorescence emitted by albumin-metalloporphyrin complex after pulsed light excitation. PQM is independent of the dye concentration within the tissue and is well suited for detecting hypoxia, because its decay time is inversely proportional to the PO 2 level, causing the method to be more precise at low PO2. This technique is used to measure intravascular and extravascular PO2, since the albumin-dye complex continuously extravasates the circulation into the interstitial fluid (21, 36) . Extravascular fluid PO 2 (interstitial fluid) was measured in tissue regions between functional capillaries. PQM allows for precise localization of the PO 2 measurements without subjecting the tissue to injury. These measurements provide a detailed understanding of microvascular O 2 distribution and indicate whether O2 is delivered to the interstitial areas.
O2 delivery and extraction. The microvascular methodology used in our studies allows a detailed analysis of O2 supply in the tissue. Calculations are made using Eqs. 1 and 2 (7)
where RBC Hb is Hb from RBCs [i.e., total Hb Ϫ plasma Hb (g Hb/dl blood)], plasmaHb is acellular Hb (g Hb/dl blood), ␥ is O2-carrying capacity of saturated Hb (1.34 ml O2/g Hb), SA is arteriolar blood O2 saturation, Š A is arteriolar acellular Hb O2 saturation, A-V indicates arteriolar-venular differences, and Q is microvascular flow. O2 saturations were measured as described above. Data analysis. Results are presented as means Ϯ SD. The boxwhisker plot separates the data into quartiles, with the top of the box defining the 75th percentile, the line within the box the median, and the bottom of the box the 25th percentile. The upper "whisker" defines the 95th percentile and the lower whisker the 5th percentile. Grubbs' method was used to assess closeness for all measured parameter values at baseline. This method quantifies how far each parameter value is from the other values obtained, computing a P value supposing that all the values were really sampled from a Gaussian population. Data within each group were analyzed using analysis of variance for repeated measurements (ANOVA, Kruskal-Wallis test). When appropriate, post hoc analyses were performed with Dunn's multiple comparison test. Microhemodynamic data are presented as absolute values and ratios relative to baseline values. A ratio of 1.0 signifies no change from baseline; lower and higher ratios are indicative of changes proportionally lower and higher than baseline (i.e., 1.5 would mean a 50% increase from the baseline level). The same vessels and capillary fields were followed, so that direct comparisons with their baseline levels could be performed, allowing for more robust statistics for small sample populations. All statistics were calculated using Prism 4.01 (GraphPad Software, San Diego, CA). Changes were considered statistically significant if P Ͻ 0.05.
RESULTS
Eighteen animals entered the study; all animals tolerated the entire hemodilution protocol without visible signs of discomfort. The animals were randomly assigned to the following experimental groups: MH (n ϭ 6, 62 Ϯ 4 g), Dex70 (n ϭ 6, 63 Ϯ 3 g), and PEG-Hb (n ϭ 6, 60 Ϯ 3 g). All animals included in the study passed the Grubbs' test, ensuring that all the measured parameter values at baseline were within a similar population (P Ͻ 0.05). Similarities between groups at baseline and prior randomization were statistically verified among groups (P Ͼ 0.30).
Systemic parameters. The first and second hemodilution exchanges with Dex70 significantly reduced Hct and Hb. Blood gas parameters are presented in Table 1 . Exchange with PEG-Hb and Dex70 decreased Hct to a similar degree. PEG-Hb presented higher total Hb compared with Dex10 due to the acellular Hb. MAP did not decrease from baseline after the first exchange with Dex70 (101 Ϯ 6 mmHg), and upon the second hemodilution step, MAP significantly decreased from baseline. MAP and HR are presented in Table 1 . Arterial blood gas analysis showed a significant increase in arterial PO 2 and PCO 2 from baseline for all groups. Arterial pH was not different from baseline, although PEG-Hb was different from Dex70. Base excess was significantly reduced for Dex70 compared with baseline, MH, and PEG-Hb. Comparison of rheological properties and COP of the blood for all study groups is presented in Table 2 . Microhemodynamics. Microvascular changes, i.e., diameter, RBC velocity, and blood flow in arterioles (46 -78 and 44 -80 m), were measured after each hemodilution step. Microvascular diameter and blood flow are presented in Fig. 1, A and D . Arteriolar diameter was unchanged after the first exchange. MH produced arteriolar dilation from baseline. Extreme hemodilution with Dex70 and PEG-Hb restored arteriolar vessel diameter to baseline. Venule diameters were not different from baseline after MH. Extreme hemodilution with Dex70 constricted venules compared with baseline and MH. Venular diameters with PEG-Hb were not different from baseline.
RBC velocity in arterioles and venules is presented in Fig. 1 FCD. FCD is shown in Fig. 2 . MH decreased FCD from baseline. After extreme hemodilution with Dex70 and PEGHb, FCD was further reduced from baseline and MH.
Microvascular O 2 distribution. Intravascular and extravascular PO 2 is presented in Fig. 3 . Increasing plasma O 2 -carrying capacity with PEG-Hb significantly increased arteriolar PO 2 compared with Dex70, although venular and extravascular PO 2 were not different among extreme hemodiluted groups. According to previous studies, normal extravascular PO 2 for the hamster window model is 21.7 Ϯ 3.5 Torr (22) .
Calculated O 2 delivery and extraction. Figure 4 shows the analysis of O 2 delivery and extraction in the microcirculation. PEG-Hb increased microvascular O 2 delivery and extraction compared with Dex70. The contribution of native RBCs was similar among extreme hemodiluted groups.
NADH levels. Figure 5 shows NADH fluorescence from baseline. MH increased NADH fluorescence from baseline. Extreme hemodilution with Dex70 and PEG-Hb increased NADH fluorescence compared with baseline and MH. NADH fluorescence was higher for Dex70 than PEG-Hb.
DISCUSSION
The principal finding of this study is that extreme hemodilution (11% Hct) with PEG-Hb and Dex70 produced similar (25) . Our results show that PEG-Hb increases O 2 delivery in conditions where native O 2 -carrying capacity is severely decreased. In the extreme anemic conditions of this study (11% Hct), RBCs are Ͻ50% saturated with O 2 (hamster P 50 is 32 Torr) as they arrive at the microcirculation, while at the microcirculation the high O 2 affinity of PEG-Hb was Ͼ95% saturated with O 2 , and, therefore, higher concentrations of O 2 were available to the tissue. The PEG-Hb used in this study was produced by a one-step method of OxyHb thiolation and PEG maleimidation; it offers a simple, reliable method to produce and modify Hb to produce an O 2 carrier. The six succinimidophenyl PEG chains were conjugated through EAC onto thiolated human Hb. Two PEG chains were conjugated to the thiols of ␤-Cys 93 units of the Hb, and four were conjugated to the ε-amino groups of lysine residues distributed on the individual ␣-and ␤-globin subunits of the Hb. The PEG mass distribution (5 kDa) is narrow; thus the sites of modification under the standardized reaction conditions had limited variability. The thiolation/PEGylation reaction conditions with OxyHb narrow the number of sites from 20 potential sites of modification identified (3, 26) .
In these experiments of extreme hemodilution with PEG-Hb, ϳ22% of the total Hb was acellular Hb. This fraction of plasma Hb provided 27% of the microvascular O 2 delivered and 20% of the total microvascular O 2 extracted. Conversely, microvascular O 2 extraction when extreme hemodilution was induced with a non-O 2 carrier (Dex70) was only 78% of that when PEG-Hb was present in the circulation. PEG-Hb also led to higher FCD after extreme hemodilution, an additional factor that promotes O 2 release. Thus, O 2 release, by high-O 2 -affinity Hb solutions, such as PEG-Hb, partially prevented tissue anoxic states, as supported by the measured NADH fluorescence.
The principal microhemodynamic difference between extreme hemodilution with PEG-Hb and Dex70 was capillary perfusion (FCD). In studies of resuscitation from hemorrhagic shock, FCD was a more reliable indicator of survival than blood flow or tissue PO 2 (22) . Microvascular perfusion is governed by FCD, which is regulated by arteriolar tone (7, 8) . Vascular tone is controlled, to a large degree, by NO, primarily generated by endothelial NO (28) . When acellular Hb solutions are present in the circulation, NO reacts rapidly with acellular OxyHb to produce methemoglobin and nitrate (16) . This rapid and irreversible reaction at high concentrations of intravascular acellular OxyHb implies that the endothelium-derived NO is insufficient for normal autocrine diffusion to smooth muscle (16, 33) . Our results suggest that a plasma PEG-Hb concentration of ϳ1 g Hb/dl is insufficient for causing a significant inactivation of endothelial NO. 1) large Hb molecules have slow diffusion properties and, therefore, do not overload arterioles with O 2 (a cause of vasoconstriction due to metabolic autoregulation); and 2) Hb molecules with large hydrodynamic diameter are not effective NO scavengers, because they do not extravasate and intercalate between the endothelium and smooth muscle. Given the proposed sequence of events that follows infusion of acellular Hb, a critical parameter for successful acellular HbOCs is to reduce molecular diffusivity by increasing size and viscosity, according to the Stokes-Einstein law. The diffusion coefficient for acellular Hb increases proportionally to the absolute temperature and inversely to the solution viscosity and molecular radius. PEG-Hb has increased molecular radius and viscosity compared with early-generation HbOCs (26, 41) . Comparative analysis of the results obtained in the hamster window model tends to support the O 2 autoregulation mechanism, since vasoconstriction has been observed with mostly low-O 2 -affinity Hb solutions. Low-affinity Hb solutions release O 2 prior to arriving to the microcirculation, which activates the autoregulatory mechanism to limit O 2 delivery by increasing peripheral vascular resistance.
MAP was higher in PEG-Hb than Dex70 animals, however, a simple mathematical approximation of vascular resistance using the Hagen-Poiseuille equation indicated that local resistances were not different at the microvascular level, since diameter, velocity, and blood flow were not different between groups. This supports the concept that low precapillary (arteriolar) O 2 release prevents arteriolar vasoconstriction, allowing systemic pressure to arrive at the capillary network (8) . Our microvascular results with PEG-Hb are similar to previous findings showing maintenance of microvascular function and FCD within normal physiological limits after hemodilution (9, 37) . During extreme hemodilution, only high-viscosity plasma expanders maintain FCD by redistributing microvascular pressure (8) . However, PEG-Hb does not increase plasma viscosity; therefore, PEG-Hb efficacy should be attributable to its O 2 -carrying capacity properties (high O 2 affinity and moderate concentration) (18, 37) .
NADH is a naturally occurring fluorophore that transfers electrons by means of an electron transport chain located in the inner membrane of mitochondria (10, 34, 35 Fig. 4 . Accordingly, the intravascular presence of high-O 2 -affinity PEG-Hb increases calculated microvascular O 2 delivery and extraction, results that are partially verified with the measurement of NADH fluorescence. O 2 transport from the blood to intracellular mitochondria is a process governed by the law of diffusion. Therefore, PO 2 should be substantially lower at the mitochondria than in the extracellular fluid and the blood vessel lumen. Although accurate measurements of cellular and intracellular O 2 gradients remained elusive because of technical difficulties, it is highly likely that the mitochondria have lower local PO 2 than other cell compartments, such as the cytoplasm (27) .
NADH fluorescence was used in this study as a marker for tissue O 2 state. Results are presented as changes relative to baseline. In vivo fluorescence from reduced pyridine nucleotides, NADH, can be difficult to distinguish from reduced NADPH because of spectral and temporal emission similarities (39) . Thus the fluorescence measured could be the sum of both, although their relative contributions cannot be determined. Therefore, some caution must be used when interpreting these data. NADPH is used extensively in biosynthetic pathways in major organs (15, 30, 35) , but these pathways are not present in the muscle and skin tissue. Furthermore, previous studies in this type of tissue report small cellular concentrations of NADPH compared with NADH (15, 30, 39) . Additionally, interpretation of fluorescence measurements from tissue can be confounded by tissue heterogeneity. However, in the hamster window model, the tissue is a thin preparation, precluding this problem.
After MH, extravascular PO 2 decreased slightly from baseline (21.7 Ϯ 3.5 Torr at baseline and 18.2 Ϯ 2.4 Torr with MH), and, surprisingly, NADH fluorescence increased 40% from baseline. The increase in NADH fluorescence is not due to changes in optical properties of the tissue, since our tech- nique normalizes the NADH fluorescence signal (460 nm) relative to the tissue optical properties at 420 nm. Use of two tissue isobestic wavelengths accounts for possible alterations in myoglobin light absorption, water content, and other fluorescent elements (32) . Additionally, because NADH fluorescence was measured at locations without blood vessels, change in blood properties (blood light absorption) should not affect our results. Therefore, the increase in NADH fluorescence after MH is likely to be an indication of tissue O 2 deficit or disruption of cellular O 2 balance.
In conclusion, a general problem in supplying O 2 to the tissues is transport of O 2 from the lung with minimal losses, so that the bulk of O 2 can be released where needed, rather than in compartments with an adequate O 2 supply. Molecular Hb solutions have the capacity to enhance O 2 transport from blood to tissue because of facilitated diffusion and the direct molecular contact between the O 2 carrier and the blood vessel wall. Conversely, the introduction of a high-O 2 -affinity acellular Hb allows for O 2 to remain in the circulating blood, while allowing its release in O 2 -deficient localities, such as the capillaries, without triggering autoregulatory protective mechanisms. Arterial O 2 content and extravascular PO 2 are basic indicators of appropriate tissue O 2 supply; however, in conditions close to extreme anoxia, NADH levels should be a more reliable indicator of tissue metabolic conditions. In this context, the presence of moderate concentrations of a high-affinity acellular Hb in the circulation appears to significantly improve oxidative metabolism in the tissue during extreme anemic conditions.
